LUKAS SCHEIBLER Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for LUKAS SCHEIBLER.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of LUKAS SCHEIBLER. LUKAS SCHEIBLER is EVP of Research & Development in ACUCELA INC. ($M??????) and EVP of Translational Medicine in ACUCELA INC. ($M??????) and CHIEF INNOVATION OFFICER in Apellis Pharmaceuticals, Inc. ($APLS) and See Remarks in Apellis Pharmaceuticals, Inc. ($APLS).

Latest Insider Trading Transactions of LUKAS SCHEIBLER

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, APLS, M??????

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 11 2021APLSApellis Pharmaceut ...SCHEIBLER LUKASCHIEF INNOVATION OF ...Payment of ExerciseF47.7268032,45029,29030 K to 29.3 K (-2.27 %)
Feb 01 2021APLSApellis Pharmaceut ...SCHEIBLER LUKASCHIEF INNOVATION OF ...Option ExerciseA44.9011,250505,12511,250
Feb 01 2021APLSApellis Pharmaceut ...SCHEIBLER LUKASCHIEF INNOVATION OF ...Option ExerciseA44.9045,0002,020,50045,000
Feb 01 2021APLSApellis Pharmaceut ...SCHEIBLER LUKASCHIEF INNOVATION OF ...GrantA0.001,875029,97028.1 K to 30 K (+6.67 %)
Feb 01 2021APLSApellis Pharmaceut ...SCHEIBLER LUKASCHIEF INNOVATION OF ...GrantA0.007,500028,09520.6 K to 28.1 K (+36.42 %)
Feb 01 2021APLSApellis Pharmaceut ...SCHEIBLER LUKASCHIEF INNOVATION OF ...Option ExerciseA44.9011,250505,12511,250
Feb 01 2021APLSApellis Pharmaceut ...SCHEIBLER LUKASCHIEF INNOVATION OF ...Option ExerciseA44.9045,0002,020,50045,000
Feb 01 2021APLSApellis Pharmaceut ...SCHEIBLER LUKASCHIEF INNOVATION OF ...GrantA0.001,875029,97028.1 K to 30 K (+6.67 %)
Feb 01 2021APLSApellis Pharmaceut ...SCHEIBLER LUKASCHIEF INNOVATION OF ...GrantA0.007,500028,09520.6 K to 28.1 K (+36.42 %)
Dec 09 2020APLSApellis Pharmaceut ...SCHEIBLER LUKASCHIEF INNOVATION OF ...Option ExerciseM26.737,482199,994137,518
Dec 09 2020APLSApellis Pharmaceut ...SCHEIBLER LUKASCHIEF INNOVATION OF ...BuyM26.737,482199,99420,59513.1 K to 20.6 K (+57.06 %)
Feb 12 2020APLSApellis Pharmaceut ...SCHEIBLER LUKASSee RemarksOption ExerciseA44.3356,2502,493,56356,250
Feb 12 2020APLSApellis Pharmaceut ...SCHEIBLER LUKASSee RemarksGrantA0.009,375012,3102.9 K to 12.3 K (+319.42 %)
Feb 12 2019APLSApellis Pharmaceut ...SCHEIBLER LUKASSee RemarksOption ExerciseA13.8585,0001,177,25085,000
May 29 2018APLSApellis Pharmaceut ...SCHEIBLER LUKASSee RemarksBuyP20.372,93559,7862,9350 to 2.9 K
Apr 17 2018APLSApellis Pharmaceut ...SCHEIBLER LUKASSee RemarksOption ExerciseA26.73145,0003,875,850145,000
Jul 18 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...Option ExerciseM0.002,663066,587
Jul 18 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...SellS6.501,2508,12511,10812.4 K to 11.1 K (-10.11 %)
Jul 18 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...BuyM0.002,663012,3589.7 K to 12.4 K (+27.47 %)
Jun 20 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...Option ExerciseM0.002,664069,250
Jun 20 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...SellS6.951,3009,0359,69511 K to 9.7 K (-11.82 %)
Jun 20 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...BuyM0.002,664010,9958.3 K to 11 K (+31.98 %)
May 18 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...Option ExerciseM0.002,663071,914
May 18 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...SellS6.151,2757,8418,3319.6 K to 8.3 K (-13.27 %)
May 18 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...BuyM0.002,66309,6066.9 K to 9.6 K (+38.36 %)
Apr 17 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...Option ExerciseM0.002,664074,577
Apr 17 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...SellS6.481,3208,5546,9438.3 K to 6.9 K (-15.97 %)
Apr 17 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...BuyM0.002,66408,2635.6 K to 8.3 K (+47.58 %)
Mar 20 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...Option ExerciseM0.002,663077,241
Mar 20 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...SellS7.101,2508,8755,5996.8 K to 5.6 K (-18.25 %)
Mar 20 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...BuyM0.002,66306,8494.2 K to 6.8 K (+63.62 %)
Feb 21 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...Option ExerciseM0.002,664079,904
Feb 21 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...SellS8.101,45011,7454,1865.6 K to 4.2 K (-25.73 %)
Feb 21 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...BuyM0.002,66405,6363 K to 5.6 K (+89.64 %)
Jan 20 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...Option ExerciseM0.002,663082,568
Jan 20 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...SellS8.701,47512,8332,9724.4 K to 3 K (-33.17 %)
Jan 20 2017M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...BuyM0.002,66304,4471.8 K to 4.4 K (+149.27 %)
Dec 27 2016M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...Option ExerciseM0.002,664085,231
Dec 27 2016M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...SellS8.188807,1981,7842.7 K to 1.8 K (-33.03 %)
Dec 27 2016M??????KUBOTA PHARMACEUTI ...SCHEIBLER LUKASEVP of Research & D ...BuyM0.002,66402,6640 to 2.7 K
Nov 21 2016M??????ACUCELA INC.SCHEIBLER LUKASEVP of Research & D ...Option ExerciseM0.002,663087,895
Nov 21 2016M??????ACUCELA INC.SCHEIBLER LUKASEVP of Research & D ...SellS9.352,66324,89102.7 K to 0 (-100.00 %)
Nov 21 2016M??????ACUCELA INC.SCHEIBLER LUKASEVP of Research & D ...BuyM0.002,66302,6630 to 2.7 K
Nov 15 2016M??????ACUCELA INC.SCHEIBLER LUKASEVP of Research & D ...SellS9.441,77416,74501.8 K to 0 (-100.00 %)
Oct 18 2016M??????ACUCELA INC.SCHEIBLER LUKASEVP of Research & D ...Option ExerciseM0.002,664090,558
Oct 18 2016M??????ACUCELA INC.SCHEIBLER LUKASEVP of Research & D ...Payment of ExerciseF11.4889010,2201,7742.7 K to 1.8 K (-33.41 %)
Oct 18 2016M??????ACUCELA INC.SCHEIBLER LUKASEVP of Research & D ...BuyM0.002,66402,6640 to 2.7 K
Sep 20 2016M??????ACUCELA INC.SCHEIBLER LUKASEVP of Research & D ...Option ExerciseM0.002,663093,222
Sep 20 2016M??????ACUCELA INC.SCHEIBLER LUKASEVP of Research & D ...SellS9.532,66325,38202.7 K to 0 (-100.00 %)
Sep 20 2016M??????ACUCELA INC.SCHEIBLER LUKASEVP of Research & D ...BuyM0.002,66302,6630 to 2.7 K
Aug 18 2016M??????ACUCELA INC.SCHEIBLER LUKASEVP of Research & D ...Option ExerciseM0.0031,962095,885
Aug 18 2016M??????ACUCELA INC.SCHEIBLER LUKASEVP of Research & D ...SellS10.8131,962345,509032 K to 0 (-100.00 %)
Aug 18 2016M??????ACUCELA INC.SCHEIBLER LUKASEVP of Research & D ...BuyM0.0031,962031,9620 to 32 K
Jul 14 2016M??????ACUCELA INC.SCHEIBLER LUKASEVP of Research & D ...Option ExerciseA15.4187,5551,349,22387,555
Jul 14 2016M??????ACUCELA INC.SCHEIBLER LUKASEVP of Research & D ...Option ExerciseA15.4132,445499,97732,445
Aug 19 2015M??????ACUCELA INC.SCHEIBLER LUKASEVP of Translationa ...Option ExerciseA0.00127,8470127,847

Page:   1